|
1:
|
The globular heads of C1q
specifically recognize surface blebs of apoptotic vascular endothelial cells.
J Immunol. 2001 Mar 1;166(5):3231-9.
PMID: 11207277 [PubMed - indexed for MEDLINE]
|
2:
|
Apoptosis and autoimmunity:
complement deficiency and systemic lupus erythematosus revisited.
Curr Rheumatol Rep. 2000 Feb;2(1):32-8. Review.
PMID: 11123037 [PubMed - indexed for MEDLINE]
|
3:
|
Johnson
AA, Mirowski Rosengard A, Skjodt K, Ahearn JM, Leslie RG. |
The structural basis for complement
receptor type 2 (CR2, CD21)-mediated alternative pathway activation of
complement: studies with CR2 deletion mutants and vaccinia virus
complement-control protein-CR2 chimeras.
Eur J Immunol. 1999 Dec;29(12):3837-44.
PMID: 10601991 [PubMed - indexed for MEDLINE]
|
4:
|
Rosengard
AM, Alonso LC, Korb LC, Baldwin WM 3rd, Sanfilippo F, Turka LA, Ahearn JM. |
Functional characterization of
soluble and membrane-bound forms of vaccinia virus complement control protein
(VCP).
Mol Immunol. 1999 Jul;36(10):685-97.
PMID: 10509819 [PubMed - indexed for MEDLINE]
|
5:
|
Viral complement regulatory
proteins.
Immunopharmacology. 1999 May;42(1-3):99-106.
Review.
PMID: 10408371 [PubMed - indexed for MEDLINE]
|
6:
|
Systemic lupus erythematosus and
complement deficiency: clues to a novel role for the classical complement
pathway in the maintenance of immune tolerance.
Immunopharmacology. 1999 May;42(1-3):47-52.
Review.
PMID: 10408365 [PubMed - indexed for MEDLINE]
|
7:
|
C1q binds directly and specifically
to surface blebs of apoptotic human keratinocytes: complement deficiency and
systemic lupus erythematosus revisited.
J Immunol. 1997 May 15;158(10):4525-8.
PMID: 9144462 [PubMed - indexed for MEDLINE]
|
8:
|
Karp
CL, Wysocka M, Wahl LM, Ahearn JM, Cuomo PJ, Sherry B, Trinchieri G, Griffin
DE. |
Mechanism of suppression of
cell-mediated immunity by measles virus.
Science. 1996 Jul 12;273(5272):228-31.
PMID: 8662504 [PubMed - indexed for MEDLINE]
|
9:
|
Croix
DA, Ahearn JM, Rosengard AM, Han S, Kelsoe G, Ma M, Carroll MC. |
Antibody response to a T-dependent
antigen requires B cell expression of complement receptors.
J Exp Med. 1996 Apr 1;183(4):1857-64.
PMID: 8666942 [PubMed - indexed for MEDLINE]
|
10:
|
Ahearn
JM, Fischer MB, Croix D, Goerg S, Ma M, Xia J, Zhou X, Howard RG, Rothstein
TL, Carroll MC. |
Disruption of the Cr2 locus results
in a reduction in B-1a cells and in an impaired B cell response to T-dependent
antigen.
Immunity. 1996 Mar;4(3):251-62.
PMID: 8624815 [PubMed - indexed for MEDLINE]
|
11:
|
Binding of human immunodeficiency
virus type 1 to the C3b/C4b receptor CR1 (CD35) and red blood cells in the
presence of envelope-specific antibodies and complement. National Institutes of
Health AIDS Vaccine Clinical Trials Networks.
J Infect Dis. 1994 Aug;170(2):429-32.
PMID: 8035031 [PubMed - indexed for MEDLINE]
|
12:
|
Determination of the role for CD21
during Epstein-Barr virus infection of B-lymphoblastoid cells.
J Virol. 1994 Aug;68(8):4716-26.
PMID: 7913508 [PubMed - indexed for MEDLINE]
|
13:
|
Matsumoto
AK, Martin DR, Carter RH, Klickstein LB, Ahearn JM, Fearon DT. |
Functional dissection of the
CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes.
J Exp Med. 1993 Oct 1;178(4):1407-17.
PMID: 7690834 [PubMed - indexed for MEDLINE]
|
14:
|
Complement-mediated binding of
naturally glycosylated and glycosylation-modified human immunodeficiency virus
type 1 to human CR2 (CD21).
J Virol. 1993 May;67(5):2699-706.
PMID: 8474169 [PubMed - indexed for MEDLINE]
|
15:
|
Kalli
KR, Hsu PH, Bartow TJ, Ahearn JM, Matsumoto AK, Klickstein LB, Fearon DT. |
Mapping of the C3b-binding site of
CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor.
J Exp Med. 1991 Dec 1;174(6):1451-60.
PMID: 1836011 [PubMed - indexed for MEDLINE]
|
16:
|
Determination of the structural
basis for selective binding of Epstein-Barr virus to human complement receptor
type 2.
J Exp Med. 1991 Dec 1;174(6):1299-311.
PMID: 1660522 [PubMed - indexed for MEDLINE]
|
17:
|
Suppression of the immune response
by a soluble complement receptor of B lymphocytes.
Science. 1991 Oct 4;254(5028):102-5.
PMID: 1718035 [PubMed - indexed for MEDLINE]
|
18:
|
Interaction of iC3b with
recombinant isotypic and chimeric forms of CR2.
J Immunol. 1991 Jul 15;147(2):590-4.
PMID: 1830068 [PubMed - indexed for MEDLINE]
|
19:
|
Molecular interactions of
complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the
CR2/CD19 complex.
J Exp Med. 1991 May 1;173(5):1083-9.
PMID: 1708808 [PubMed - indexed for MEDLINE]
|
20:
|
Complement receptor type 1 (C3b/C4b
receptor; CD35) and complement receptor type 2 (C3d/Epstein-Barr virus
receptor; CD21).
Curr Top Microbiol Immunol. 1990;153:83-98.
Review. No abstract available.
PMID: 2153507 [PubMed - indexed for MEDLINE]
|
21:
|
Lowell
CA, Klickstein LB, Carter RH, Mitchell JA, Fearon DT, Ahearn JM. |
Mapping of the Epstein-Barr virus
and C3dg binding sites to a common domain on complement receptor type 2.
J Exp Med. 1989 Dec 1;170(6):1931-46.
PMID: 2479703 [PubMed - indexed for MEDLINE]
|
22:
|
Ahearn
JM Jr, Calomiris JJ, Wigley FM, Jabs DA, Bias WB, Hochberg MC. |
Characterization of the class I HLA
9.2-kb PVU II restriction fragment length polymorphism. Linkage to HLA-A and
lack of disease association.
Arthritis Rheum. 1989 Jul;32(7):870-6.
PMID: 2568835 [PubMed - indexed for MEDLINE]
|
23:
|
Structure and function of the
complement receptors, CR1 (CD35) and CR2 (CD21).
Adv Immunol. 1989;46:183-219. Review. No
abstract available.
PMID: 2551147 [PubMed - indexed for MEDLINE]
|
24:
|
Epstein-Barr virus (EBV) infection
of murine L cells expressing recombinant human EBV/C3d receptor.
Proc Natl Acad Sci U S A. 1988
Dec;85(23):9307-11.
PMID: 2848261 [PubMed - indexed for MEDLINE]
|
25:
|
Epidemiology and genetics of
ankylosing spondylitis.
J Rheumatol Suppl. 1988 Sep;16:22-8. Review.
PMID: 3057207 [PubMed - indexed for MEDLINE]
|
26:
|
Cloning and sequence analysis of
the mouse genomic locus encoding the largest subunit of RNA polymerase II.
J Biol Chem. 1987 Aug 5;262(22):10695-705.
PMID: 3038894 [PubMed - indexed for MEDLINE]
|
27:
|
A unique structure at the carboxyl
terminus of the largest subunit of eukaryotic RNA polymerase II.
Proc Natl Acad Sci U S A. 1985
Dec;82(23):7934-8.
PMID: 2999785 [PubMed - indexed for MEDLINE]
|
28:
|
Hochberg
MC, Boyd RE, Ahearn JM, Arnett FC, Bias WB, Provost TT, Stevens MB. |
Systemic lupus erythematosus: a
review of clinico-laboratory features and immunogenetic markers in 150 patients
with emphasis on demographic subsets.
Medicine (Baltimore). 1985 Sep;64(5):285-95.
PMID: 2412088 [PubMed - indexed for MEDLINE]
|
29:
|
Alvarellos
A, Ahearn JM, Provost TT, Dorsch CA, Stevens MB, Bias WB, Arnett FC. |
Relationships of HLA-DR and MT
antigens to autoantibody expression in systemic lupus erythematosus.
Arthritis Rheum. 1983 Dec;26(12):1533-5. No
abstract available.
PMID: 6418180 [PubMed - indexed for MEDLINE]
|
30:
|
Ahearn
JM, Provost TT, Dorsch CA, Stevens MB, Bias WB, Arnett FC. |
Interrelationships of HLA-DR, MB,
and MT phenotypes, autoantibody expression, and clinical features in systemic
lupus erythematosus.
Arthritis Rheum. 1982 Sep;25(9):1031-40. No
abstract available.
PMID: 6957194 [PubMed - indexed for MEDLINE]